Anti-vascular permeability of the cleaved reactive center loop within the carboxyl-terminal domain of C1 inhibitor

Molecular Immunology

Volumn 45, Issue 6, 2008, Pages 1743-1751

  Cheng, Zhi De ^a   Liu, Meng Yuan ^a   Chen, Gao ^a   Zhang, Hai Mou ^a   Qin, Gang Jian ^b   Liang, Gang ^c   Liu, Dong Xu ^a  

^a HUBEI UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adhesion molecule; C1 inhibitor; Endothelial cell; Lipopolysaccharide

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERINE PROTEINASE INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ACTIVITY; CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXPERIMENTAL ANIMAL; GRAM NEGATIVE BACTERIUM; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN; UPREGULATION; VASCULAR ENDOTHELIUM;

AMINO ACID MOTIFS; ANIMALS; CAPILLARY PERMEABILITY; CELL ADHESION; CELLS, CULTURED; COMPLEMENT C1 INHIBITOR PROTEIN; CYTOSKELETON; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; NF-KAPPA B; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

BACTERIA (MICROORGANISMS); MUS; NEGIBACTERIA;

EID: 38949096439     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.09.035     Document Type: Article

References (36)

1. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 (2003) 3765-3777
2. Bannerman D.D., and Goldblum S.E. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation. Am. J. Physiol. 273 (1997) L217-L226
3. Bannerman D.D., and Goldblum S.E. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 284 (2003) L899-L914
4. Bannerman D.D., Sathyamoorthy M., and Goldblum S.E. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J. Biol. Chem. 273 (1998) 35371-35380
5. Bannerman D.D., Fitzpatrick M.J., Anderson D.Y., Bhattacharjee A.K., Novitsky T.J., Hasday J.D., Cross A.S., and Goldblum S.E. Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction. Infect. Immun. 66 (1998) 1400-1407
6. Bannerman D.D., Tupper J.C., Ricketts W.A., Bennett C.F., Winn R.K., and Harlan J.M. A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J. Biol. Chem. 276 (2001) 14924-14932
7. Brandtzaeg P., Kierulf P., Gaustad P., Skulberg A., Bruun J.N., Halvorsen S., and Sorensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 59 (1989) 195-204
8. Brigham K.L., and Meyrick B. Endotoxin and lung injury. Am. Rev. Respir. Dis. 133 (1986) 913-927
9. 2 plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. J. Biol. Chem. 257 (1982) 9849-9854
10. Cai S., and Davis III A.E. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J. Immunol. 171 (2003) 4786-4791
11. Caliezi C., Wuillemin W.A., Zeerleder S., Redondo M., Eisele B., and Hack C.E. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol. Rev. 52 (2001) 91-112
12. Carrell R.W., Christey P.B., and Boswell D.R. Serpins: antithrombin and other inhibitors of coagulation and fibrinolysis. Evidence from amino acid sequences. In: Verstraete M., Vermylen J., Lijnen R., and Arnout J. (Eds). Thrombosis and Haemostasis (1987), Leuven University Press, Leuven 1-15
13. Chakravortty D., and Nanda Kumar K.S. Bacterial lipopolysaccharide induces cytoskeletal rearrangement in small intestinal lamina propria fibroblasts: actin assembly is essential for lipopolysaccharide signaling. Biochem. Biophys. Acta 1500 (2000) 125-136
14. Chakravortty D., Koide N., Kato Y., Sugiyama T., Kawai M., Fukada M., Yoshida T., and Yokochi T. Cytoskeletal alterations in lipopolysaccharide-induced bovine vascular endothelial cell injury and its prevention by sodium arsenate. Clin. Diagn. Lab. Immunol. 7 (2000) 218-225
15. Choi K., Wong F., Harlan J.M., Chaudhary P.M., Hood L., and Karsan A. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J. Biol. Chem. 273 (1998) 20185-20188
16. Davis III A.E., Cai S., and Liu D. The biologic role of C1 inhibitor in regulation of vascular permeability and modulation of inflammation. Adv. Immunol. 82 (2004) 331-362
17. De Boer J.P., Creasey A.A., Chang A., Roem D., Eerenberg A.J.M., Hack C.E., and Taylor F.B. Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect. Immun. 61 (1993) 4293-4301
18. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone Jr. M.A., Shin W.S., and Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96 (1995) 60-68
19. Fujii E., Irie K., Ogawa A., Ohba K., and Muraki T. Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur. J. Pharm. 297 (1996) 257-263
20. Goldblum S.E., Ding X., Brann T.W., and Campbell-Washington J. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J. Cell Physiol. 157 (1993) 13-23
21. Goldblum S.E., Brann T.W., Ding X., Pugin J., and Tobias P.S. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J. Clin. Invest. 93 (1994) 692-702
22. Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., Garzotto M., McLoughlin M., Gallily R., Edwards III C.K., Schuchman E.H., Fuks Z., and Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186 (1997) 1831-1841
23. Harlan J.M., Harker L.A., Reidy M.A., Gajdusek C.M., Schwartz S.M., and Striker G.E. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab. Invest. 48 (1983) 269-274
24. Harlan J.M., Harker L.A., Striker G.E., and Weaver L.J. Effects of lipopolysaccharide on human endothelial cells in culture. Thromb. Res. 29 (1983) 15-26
25. Huntington J.A., Read R.J., and Carrell R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407 (2000) 923-926
26. Kirschfink M., and Nurnberger W. C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application. Mol. Immunol. 36 (1999) 225-232
27. Liu D., Cai S., Gu X., Scafidi J., Wu X., and Davis III A.E. C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J. Immunol. 171 (2003) 2594-2601
28. Liu D., Gu X., Scafidi J., and Davis III A.E. N-linked glycosylation is required for C1 inhibitor-mediated protection from endotoxin shock in mice. Infect. Immun. 72 (2004) 1946-1955
29. Liu D., Zhang D., Scafidi J., Wu X., Cramer C.C., and Davis III A.E. C1 inhibitor prevents gram-negative bacterial lipopolysaccharide-induced vascular permeability. Blood 105 (2005) 2350-2355
30. Liu D., Cramer C.C., Scafidi J., and Davis III A.E. N-linked glycosylation site Asn3 and the positively charged amino acids at the terminal domain are responsible for interaction of C1 inhibitor with gram-negative bacterial lipopolysaccharide. Infect. Immun. 73 (2005) 4478-4487
31. Loebermann H., Tokuoka R., Deisenhofer J., and Huber R. Human α1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177 (1984) 531-557
32. Meyrick B.O., Ryan U.S., and Brigham K.L. Direct effects of E. coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am. J. Pathol. 122 (1986) 140-151
33. Nuijens J.H., Eerenberg-Belmer A.J., Huijbregts C.C., Schreuder W.O., Felt-Bersma R.J., Abbink J.J., Thijs L.G., and Hack C.E. Proteolytic inactivation of plasma C1 inhibitor in sepsis. J. Clin. Invest. 84 (1989) 443-450
34. Thijs L.G., Groeneveld A.B., and Hack C.E. Multiple organ failure in septic shock. Curr. Top. Microbiol. Immunol. 216 (1996) 209-237
35. Wallace E.M., Perkins S.J., Sim R.B., Willis A.C., Feighery C., and Jackson J. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory process. Mol. Med. 3 (1997) 385-396
36. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 320 (1989) 365-376